p.73 抽出テキスト

............................................................................................... 9 Appendix

Author/Task Force Member Affiliations: Sonya V. Babu-Narayan, NHLI, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom; Werner Budts, Congenital and Structural Cardiology, UZ Leuven and Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium; Massimo Chessa, ACHD Unit, Paediatric and Adult Congenital Heart Centre, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy; Gerhard-Paul Diller, Department of Cardiology III, Adult Congenital and Valvular Heart Disease, University Hospital, Muenster, Germany; Bernard Iung, Cardiology, Bichat Hospital, Paris, France; Jolanda Kluin, Cardiothoracic Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Irene M. Lang, Cardiology, Medical University of Vienna, Vienna, Austria; Folkert Meijboom, Cardiology, University Medical Centre Utrecht, Utrecht, Netherlands; Philip Moons, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium, and Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden and Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; Barbara J. M. Mulder, Cardiology, Amsterdam University Medical Center, Amsterdam, Netherlands; Erwin Oechslin, Medicine, Division of Cardiology, Peter Munk Cardiac Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada; Jolien W. Roos- Hesselink, Cardiology, Erasmus MC, Rotterdam, Netherlands; Markus Schwerzmann, Center for Congenital Heart Disease, Department of Cardiology, University Hospital Inselspital, University of Bern, Bern, Switzerland; Lars Sondergaard, Cardiology, Rigshospitalet, Copenhagen, Denmark; Katja Zeppenfeld, Leiden University Medical Centre, Leiden, Netherlands.

ESC Committee for Practice Guidelines (CPG): Stephan Windecker (Chairperson) (Switzerland), Victor Aboyans (France), Colin Baigent (United Kingdom), Jean-Philippe Collet (France), Veronica Dean (France), Victoria Delgado (Netherlands), Donna Fitzsimons (United Kingdom), Chris P. Gale (United Kingdom), Diederick E. Grobbee (Netherlands), Sigrun Halvorsen (Norway), Gerhard Hindricks (Germany), Bernard Iung (France), Peter Ju ̈ni (Canada), Hugo A. Katus (Germany), Ulf Landmesser (Germany), Christophe Leclercq (France), Maddalena Lettino (Italy), Basil S. Lewis (Israel), Be ́la Merkely (Hungary), Christian Mueller (Switzerland), Steffen E. Petersen (United Kingdom), Anna Sonia Petronio (Italy), Dimitrios J. Richter (Greece), Marco Roffi (Switzerland), Evgeny Shlyakhto (Russian Federation), Iain A. Simpson (United Kingdom), Miguel Sousa-Uva (Portugal), Rhian M. Touyz (United Kingdom). ESC National Cardiac Societies actively involved in the review process of the 2020 ESC Guidelines for the management of adult congenital heart disease. Algeria: Algerian Society of Cardiology, Naima Hammoudi; Armenia: Armenian Cardiologists Association, Svetlana V. Grigoryan; Austria: Austrian Society of Cardiology, Johannes Mair; Azerbaijan: Azerbaijan Society of Cardiology, Galib Imanov; Belarus: Belorussian Scientific Society of Cardiologists, Jouri Chesnov; Belgium: Belgian Society of Cardiology, Antoine Bondue; Bosnia and Herzegovina: Association of Cardiologists of Bosnia and Herzegovina, Naser Nabil; Bulgaria: Bulgarian Society of Cardiology, Anna Kaneva; Croatia: Croatian Cardiac Society,

Anomalous coronary arteries Non-pharmacological functional imaging (e.g. nuclear study, echocardiography, or CMR with physical stress) is recommended in patients with coronary anomalies to confirm/exclude myocardial ischaemia. I C Anomalous coronary arteries from the pulmonary artery Surgery is recommended in patients with ALCAPA. I C Surgery is recommended in patients with ARCAPA and symptoms attributable to anomalous coronary artery. I C Anomalous aortic origin of the coronary artery Surgery is recommended for AAOCA in patients with typical angina symptoms who present with evidence of stress-induced myocardial ischaemia in a matching territory or high-risk anatomy. I C Surgery is not recommended for AAORCA in asymptomatic patients without myocardial ischaemia and without high-risk anatomy. III C

AAOCA = anomalous aortic origin of a coronary artery; AAORCA anomalous aortic origin of the right coronary artery; ACHD = adult congenital heart disease; ALCAPA = anomalous left coronary artery from the pulmonary artery; ARCAPA = anomalous right coronary artery from the pulmonary artery; AR = aortic regurgitation; AS = aortic stenosis; ASD = atrial septal defect; AT = atrial tachycardia; AV = atrioventricular; AVNRT = atrioventricular node reentrant tachycardia; AVRT = atrioventricular reentrant tachycardia; AVSD = atrioventricular septal defect; CABG = coronary artery bypass graft; CAD = coronary artery disease; CHD = congenital heart disease; CMR = cardiovascular magnetic resonance; ECG = electrocardiogram; EF = ejection fraction; EP = electrophysiology/electrophysiological; HTAD = heritable thoracic aortic disease; IART= intraatrial reentrant tachycardia; ICD = implantable cardioverter defibrillator; LR = left-to-right; LV = left ventricle/ventricular; LVEF = left ventricular ejection fraction; LVESD = left ventricular end systolic diameter; PAH = pulmonary arterial hypertension; PAP = pulmonary arterial pressure; PAH-CHD = pulmonary arterial hypertension associated with congenital heart disease; PDA = patent ductus arteriosus; PFO = patent foramen ovale; PH = pulmonary hypertension; PR = pulmonary regurgitation; PS = pulmonary stenosis; PVR = pulmonary vascular resistance; PVRep = pulmonary valve replacement; RL = right-to-left; RV = right ventricle/ventricular; RVOTO = right ventricular outflow tract obstruction; RVSP = right ventricular systolic pressure; SCD = sudden cardiac death; SVT = supraventricular tachycardia; TPVI = transcatheter pulmonary valve implantation; TR = tricuspid regurgitation; TV = tricuspid valve; UVH = univentricular heart; VF = ventricular fibrillation; VSD = ventricular septal defect; VT = ventricular tachycardia; WU = Wood units; aClass of recommendation. bLevel of evidence. Downloaded from academic.oup.com/eurheartj/article/42/6/563/5898606 by guest on 07 October 2026